Dolby Other Current Assets vs Inventory Analysis

DLB Stock

USD 82.81 0.18 0.22%

Dolby Laboratories financial indicator trend analysis is much more than just examining Dolby Laboratories latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dolby Laboratories is a good investment. Please check the relationship between Dolby Laboratories Other Current Assets and its Inventory accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.

Other Current Assets vs Inventory

Other Current Assets vs Inventory Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dolby Laboratories Other Current Assets account and Inventory. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Dolby Laboratories' Other Current Assets and Inventory is 0.44. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Inventory in the same time period over historical financial statements of Dolby Laboratories, assuming nothing else is changed. The correlation between historical values of Dolby Laboratories' Other Current Assets and Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Dolby Laboratories are associated (or correlated) with its Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory has no effect on the direction of Other Current Assets i.e., Dolby Laboratories' Other Current Assets and Inventory go up and down completely randomly.

Correlation Coefficient

0.44

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Inventory

Most indicators from Dolby Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dolby Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.At present, Dolby Laboratories' Issuance Of Capital Stock is projected to decrease significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 26.65, whereas Selling General Administrative is forecasted to decline to about 186.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.1B	892.2M	1.0B	771.3M
Total Revenue	1.3B	1.0B	1.2B	837.9M

Gross Profit Total Revenue

Dolby Laboratories fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		1.0	-0.8	0.87	0.91	0.6	0.95	0.45	0.67	0.67	0.8	0.94	0.72	1.0	0.43	0.94	0.6	0.68	0.62	0.91	0.51	0.87	0.58	0.59	-0.18	0.73
Total Stockholder Equity	1.0		-0.82	0.87	0.92	0.62	0.94	0.51	0.63	0.63	0.77	0.94	0.7	1.0	0.42	0.94	0.55	0.65	0.58	0.9	0.53	0.83	0.54	0.56	-0.13	0.69
Net Debt	-0.8	-0.82		-0.97	-0.94	-0.52	-0.86	-0.47	-0.5	-0.5	-0.69	-0.81	-0.33	-0.81	-0.4	-0.65	-0.51	-0.48	-0.51	-0.71	-0.43	-0.76	-0.35	-0.74	0.02	-0.6
Cash	0.87	0.87	-0.97		0.96	0.51	0.93	0.43	0.55	0.55	0.72	0.87	0.41	0.87	0.36	0.7	0.57	0.53	0.58	0.76	0.43	0.83	0.39	0.78	-0.11	0.64
Cash And Short Term Investments	0.91	0.92	-0.94	0.96		0.65	0.94	0.53	0.56	0.56	0.71	0.84	0.52	0.91	0.42	0.77	0.51	0.51	0.52	0.79	0.54	0.77	0.44	0.67	-0.04	0.63
Common Stock Shares Outstanding	0.6	0.62	-0.52	0.51	0.65		0.57	0.39	0.63	0.64	0.39	0.42	0.6	0.6	0.59	0.57	0.42	0.51	0.43	0.56	0.95	0.33	0.57	0.33	-0.12	0.62
Total Current Assets	0.95	0.94	-0.86	0.93	0.94	0.57		0.34	0.69	0.69	0.71	0.89	0.6	0.95	0.39	0.78	0.67	0.64	0.72	0.86	0.45	0.85	0.55	0.72	-0.32	0.74
Short Long Term Debt Total	0.45	0.51	-0.47	0.43	0.53	0.39	0.34		-0.18	-0.18	0.34	0.35	0.26	0.48	-0.01	0.52	-0.27	-0.2	-0.31	0.48	0.39	0.18	-0.17	0.02	0.54	-0.13
Other Current Liab	0.67	0.63	-0.5	0.55	0.56	0.63	0.69	-0.18		1.0	0.56	0.6	0.65	0.63	0.69	0.59	0.89	0.93	0.89	0.61	0.6	0.65	0.89	0.62	-0.58	0.98
Total Current Liabilities	0.67	0.63	-0.5	0.55	0.56	0.64	0.69	-0.18	1.0		0.55	0.59	0.67	0.63	0.7	0.59	0.89	0.93	0.88	0.6	0.61	0.64	0.89	0.62	-0.59	0.98
Other Liab	0.8	0.77	-0.69	0.72	0.71	0.39	0.71	0.34	0.56	0.55		0.85	0.56	0.77	0.43	0.79	0.58	0.6	0.47	0.77	0.34	0.91	0.63	0.41	0.04	0.66
Property Plant And Equipment Net	0.94	0.94	-0.81	0.87	0.84	0.42	0.89	0.35	0.6	0.59	0.85		0.55	0.94	0.35	0.89	0.61	0.7	0.62	0.86	0.34	0.94	0.53	0.56	-0.13	0.69
Current Deferred Revenue	0.72	0.7	-0.33	0.41	0.52	0.6	0.6	0.26	0.65	0.67	0.56	0.55		0.7	0.53	0.78	0.45	0.61	0.41	0.61	0.58	0.52	0.66	0.35	-0.27	0.63
Retained Earnings	1.0	1.0	-0.81	0.87	0.91	0.6	0.95	0.48	0.63	0.63	0.77	0.94	0.7		0.4	0.93	0.56	0.65	0.6	0.91	0.49	0.85	0.54	0.57	-0.17	0.69
Accounts Payable	0.43	0.42	-0.4	0.36	0.42	0.59	0.39	-0.01	0.69	0.7	0.43	0.35	0.53	0.4		0.44	0.42	0.62	0.43	0.27	0.61	0.34	0.58	0.36	-0.18	0.67
Non Current Assets Total	0.94	0.94	-0.65	0.7	0.77	0.57	0.78	0.52	0.59	0.59	0.79	0.89	0.78	0.93	0.44		0.47	0.67	0.45	0.85	0.54	0.78	0.57	0.38	-0.02	0.64
Non Currrent Assets Other	0.6	0.55	-0.51	0.57	0.51	0.42	0.67	-0.27	0.89	0.89	0.58	0.61	0.45	0.56	0.42	0.47		0.86	0.93	0.65	0.35	0.73	0.87	0.7	-0.68	0.92
Other Assets	0.68	0.65	-0.48	0.53	0.51	0.51	0.64	-0.2	0.93	0.93	0.6	0.7	0.61	0.65	0.62	0.67	0.86		0.85	0.6	0.5	0.72	0.86	0.56	-0.5	0.95
Net Receivables	0.62	0.58	-0.51	0.58	0.52	0.43	0.72	-0.31	0.89	0.88	0.47	0.62	0.41	0.6	0.43	0.45	0.93	0.85		0.61	0.32	0.68	0.75	0.68	-0.74	0.9
Good Will	0.91	0.9	-0.71	0.76	0.79	0.56	0.86	0.48	0.61	0.6	0.77	0.86	0.61	0.91	0.27	0.85	0.65	0.6	0.61		0.46	0.82	0.63	0.52	-0.26	0.67
Common Stock Total Equity	0.51	0.53	-0.43	0.43	0.54	0.95	0.45	0.39	0.6	0.61	0.34	0.34	0.58	0.49	0.61	0.54	0.35	0.5	0.32	0.46		0.26	0.52	0.31	-0.04	0.58
Non Current Liabilities Total	0.87	0.83	-0.76	0.83	0.77	0.33	0.85	0.18	0.65	0.64	0.91	0.94	0.52	0.85	0.34	0.78	0.73	0.72	0.68	0.82	0.26		0.64	0.63	-0.23	0.75
Inventory	0.58	0.54	-0.35	0.39	0.44	0.57	0.55	-0.17	0.89	0.89	0.63	0.53	0.66	0.54	0.58	0.57	0.87	0.86	0.75	0.63	0.52	0.64		0.44	-0.5	0.9
Other Current Assets	0.59	0.56	-0.74	0.78	0.67	0.33	0.72	0.02	0.62	0.62	0.41	0.56	0.35	0.57	0.36	0.38	0.7	0.56	0.68	0.52	0.31	0.63	0.44		-0.54	0.67
Other Stockholder Equity	-0.18	-0.13	0.02	-0.11	-0.04	-0.12	-0.32	0.54	-0.58	-0.59	0.04	-0.13	-0.27	-0.17	-0.18	-0.02	-0.68	-0.5	-0.74	-0.26	-0.04	-0.23	-0.5	-0.54		-0.53
Total Liab	0.73	0.69	-0.6	0.64	0.63	0.62	0.74	-0.13	0.98	0.98	0.66	0.69	0.63	0.69	0.67	0.64	0.92	0.95	0.9	0.67	0.58	0.75	0.9	0.67	-0.53

Click cells to compare fundamentals

Dolby Laboratories Account Relationship Matchups

Dolby Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.9B	3.1B	2.7B	3.0B	3.4B	2.0B
Total Stockholder Equity	2.4B	2.6B	2.2B	2.4B	2.7B	1.6B
Net Debt	(990.7M)	(1.2B)	(569.2M)	(694.7M)	(625.2M)	(656.5M)
Cash	1.1B	1.2B	620.1M	745.4M	857.2M	591.4M
Cash And Short Term Investments	1.1B	1.3B	809.3M	884.5M	1.0B	756.2M
Common Stock Shares Outstanding	102.9M	104.6M	102.0M	97.6M	112.2M	113.8M
Liabilities And Stockholders Equity	2.9B	3.1B	2.7B	3.0B	3.4B	2.0B
Total Current Assets	1.5B	1.8B	1.3B	1.5B	1.7B	1.0B
Other Current Liab	223.2M	264.1M	231.5M	356.2M	409.6M	430.1M
Total Current Liabilities	267.1M	315.7M	277.5M	422.2M	485.6M	509.8M
Other Liab	146.5M	129.0M	123.3M	148.3M	170.6M	93.7M
Property Plant And Equipment Net	618.5M	601.5M	560.0M	521.8M	600.0M	326.9M
Current Deferred Revenue	15.4M	18.5M	18.6M	31.5M	36.2M	20.5M
Retained Earnings	2.4B	2.6B	2.3B	2.4B	2.8B	1.6B
Accounts Payable	12.6M	17.8M	14.2M	20.9M	18.8M	24.1M
Non Current Assets Total	1.4B	1.3B	1.4B	1.5B	1.7B	997.2M
Non Currrent Assets Other	91.2M	61.3M	55.1M	94.7M	108.9M	114.3M
Other Assets	210.1M	217.3M	238.7M	296.5M	341.0M	358.1M
Net Receivables	341.7M	414.9M	419.7M	444.4M	511.0M	536.6M
Good Will	489.4M	340.7M	365.1M	408.4M	469.7M	281.3M
Non Current Liabilities Total	211.8M	185.7M	161.0M	185.4M	213.2M	109.4M
Inventory	25.6M	11.0M	23.5M	35.6M	41.0M	43.0M
Other Current Assets	53.0M	62.7M	23.2M	50.7M	45.6M	45.6M
Other Stockholder Equity	406K	100K	94K	(37.0M)	(33.3M)	(31.6M)
Total Liab	478.9M	501.5M	438.5M	607.6M	698.7M	733.7M
Property Plant And Equipment Gross	618.5M	601.5M	560.0M	521.8M	600.0M	326.9M
Accumulated Other Comprehensive Income	(10.6M)	(10.0M)	(51.6M)	(37.0M)	(33.3M)	(31.6M)
Short Term Debt	15.8M	15.4M	13.3M	13.6M	15.7M	16.5M
Intangible Assets	152.4M	122.9M	112.3M	167.4M	192.5M	106.4M
Property Plant Equipment	542.0M	534.4M	560.0M	521.8M	600.0M	319.4M
Short Term Investments	46.9M	38.8M	189.2M	139.1M	125.2M	138.8M
Net Tangible Assets	1.9B	2.1B	1.8B	1.8B	2.0B	1.7B

Pair Trading with Dolby Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dolby Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dolby Laboratories will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Dolby Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dolby Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dolby Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dolby Laboratories to buy it.

The correlation of Dolby Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dolby Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dolby Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Dolby Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:

How To Invest In Dolby

Details

Is Dolby Stock a good investment?

Details

What is Dolby Laboratories' Net Worth?

Details

Largest Electronic Equipment, Instruments & Components Companies

View

Largest Technology Hardware & Equipment Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Dolby Stock analysis

When running Dolby Laboratories' price analysis, check to measure Dolby Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dolby Laboratories is operating at the current time. Most of Dolby Laboratories' value examination focuses on studying past and present price action to predict the probability of Dolby Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dolby Laboratories' price. Additionally, you may evaluate how the addition of Dolby Laboratories to your portfolios can decrease your overall portfolio volatility.

	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Global Correlations Find global opportunities by holding instruments from different markets
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios

Is Dolby Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.031

Dividend Share

1.17

Earnings Share

1.94

Revenue Per Share

13.272

Quarterly Revenue Growth

(0.03)

The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dolby Other Current Assets vs Inventory Analysis

Other Current Assets vs Inventory

Other Current Assets vs Inventory Correlation Analysis

Correlation Coefficient

Other Current Assets

Inventory

Dolby Laboratories fundamental ratios Correlations

Dolby Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dolby Laboratories fundamental ratios Accounts

Pair Trading with Dolby Laboratories

Complementary Tools for Dolby Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Stockholder Equity
Total Current Liabilities	+ 1.0	Other Current Liab
Total Liab	+ 0.98	Other Current Liab
Total Liab	+ 0.98	Total Current Liabilities

Cash	- 0.97	Net Debt
Cash And Short Term Investments	- 0.94	Net Debt
Total Current Assets	- 0.86	Net Debt
Net Debt	- 0.82	Total Stockholder Equity
Retained Earnings	- 0.81	Net Debt
Property Plant And Equipment Net	- 0.81	Net Debt